Skip to main content
. 2016 Jul 4;16:379. doi: 10.1186/s12885-016-2470-3

Fig. 1.

Fig. 1

MiR-944 is suppressed in clinical tumors and breast cancer cell lines. (a) MiR-944 expression measured by qRT-PCR in breast normal adjacent and tumor tissues (discovery cohort). (b) MiR-944 expression in 776 matched normal/tumor samples from The Cancer Genome Atlas (TCGA) (validation cohort). (c) MiR-944 expression measured by qRT-PCR in breast cancer cell lines and MCF-10A non-tumorigenic cell line. Data were normalized with the endogenous small-nucleolar RNU44. Bars represent the mean of three independent experiments performed three times ± S.D. Asterisks indicate p < 0.05